News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fedora Pharmaceuticals Inc. Unveils Details of Antibiotic Resistance Program in 10 Posters at 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)


8/27/2013 8:59:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EDMONTON, Alberta, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that the Company and its collaborators will be presenting 10 posters at the upcoming Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). These presentations provide details of the Company's investigational broad-spectrum beta-lactamase inhibitor, FPI-1465. FPI-1465 is undergoing pre-clinical testing as an adjunct to antibiotics for the treatment of patients with difficult-to-treat, resistant bacterial infections. ICAAC is being held in Denver, CO September 10-13, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES